Fostamatinib works by inhibiting spleen tyrosine kinase (SYK), which plays a role in the immune response. By blocking this enzyme, fostamatinib helps to reduce the destruction of platelets by the immune system, thereby increasing platelet counts in patients with ITP.
CAT No: R2245
CAS No:901119-35-5
Chemical Name:[6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]amino]-2,2-dimethyl-3-oxopyrido[3,2-b][1,4]oxazin-4-yl]methyl dihydrogen phosphate
Fostamatinib is an orally bioavailable prodrug that, upon metabolic activation, yields the active metabolite R406—a potent and selective inhibitor of spleen tyrosine kinase (SYK). As a small-molecule kinase inhibitor, Fostamatinib is widely recognized for its capacity to modulate intracellular signaling pathways involved in immune cell activation, inflammatory processes, and hematopoietic regulation. Its biochemical profile makes it a valuable tool for researchers investigating the molecular mechanisms of SYK-mediated signal transduction and its broader implications in immunology, oncology, and hematological disorders. By providing a means to selectively target SYK, Fostamatinib enables detailed exploration of cellular processes that are critical in both physiological and pathological contexts.
Signal Transduction Research: Fostamatinib is extensively employed in the study of signal transduction pathways involving SYK, a non-receptor tyrosine kinase integral to B-cell receptor (BCR) signaling and Fc receptor-mediated processes in various immune cells. Researchers utilize this compound to dissect the downstream effects of SYK inhibition, clarifying its role in cellular activation, proliferation, and differentiation. Its specificity allows for precise interrogation of SYK-dependent signaling cascades, facilitating the identification of key molecular targets and the mapping of complex intracellular networks.
Immunology and Inflammation Studies: The compound's ability to modulate SYK activity has made it indispensable in immunological research, particularly in the context of inflammatory and autoimmune mechanisms. Experimental models frequently incorporate Fostamatinib to elucidate the function of SYK in immune cell recruitment, cytokine production, and the amplification of inflammatory responses. Such studies provide critical insights into the regulation of innate and adaptive immunity, offering a foundation for understanding the molecular basis of immune dysregulation.
Oncology Research: Fostamatinib's inhibition of SYK presents significant opportunities for cancer research, especially in hematological malignancies where aberrant SYK signaling contributes to tumor cell survival and proliferation. Investigators utilize the compound to probe the impact of SYK blockade on malignant cell lines, assess changes in apoptotic pathways, and evaluate potential mechanisms of resistance. These applications support the development of novel therapeutic strategies targeting kinase-driven oncogenic processes.
Hematopoiesis and Platelet Function Investigations: The role of SYK in hematopoietic cell development and platelet activation is a focal point for many research programs. Fostamatinib serves as a critical reagent for exploring the molecular underpinnings of platelet aggregation, megakaryocyte differentiation, and the regulation of blood cell lineages. Through its use, scientists are able to parse the contributions of SYK signaling to normal and dysregulated hematopoiesis, enhancing the understanding of blood cell physiology.
Drug Discovery and Target Validation: The compound is widely utilized in preclinical drug discovery as a reference SYK inhibitor for high-throughput screening assays and target validation studies. Its well-characterized mechanism of action provides a benchmark for evaluating the potency and selectivity of novel SYK-targeting molecules. By serving as a comparator or positive control, Fostamatinib aids in the optimization of lead compounds and the refinement of structure-activity relationships, thereby accelerating the identification of promising candidates for further research and development.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More